Omega-3 Triglyceride Trials
Thomas delves into the results of two trials involving EPA and DHA in high-risk individuals with controlled LDL cholesterol but elevated triglycerides. While EPA showed promising outcomes in reducing residual risk, the addition of DHA did not yield the same results, leaving a dilemma in understanding their combined effects on cardiovascular health.In this clip
From this podcast
The Proof with Simon Hill
Preventing and treating cardiovascular disease (Lipid Series - Part 3) | Dr Thomas Dayspring
Related Questions